Neogen Chemicals Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Neogen Chemicals (NSE: NEOGEN) is preparing to announce its Q4 FY26 financial results for the quarter ending March 31, 2026. With the stock trading at Rs 1,100 and a 52-week range of Rs 950–Rs 1,750, the Q4 FY26 results will be a pivotal event for investors tracking the Specialty Chemicals sector. This article covers the confirmed results date, Q4 FY26 analyst earnings estimates, five key performance drivers, five risks to monitor, and analyst ratings with price targets ahead of the results announcement.

Q4 FY26 (January to March 2026) is the final quarter of the financial year, carrying special importance as it determines the full-year FY26 performance baseline, sets FY27 estimate benchmarks, and typically triggers final dividend announcements. For Specialty Chemicals companies, Q4 is historically a seasonally important quarter influenced by year-end government spending, monsoon positioning, and management guidance for the year ahead.

Investors should monitor three data points when results are announced: the revenue and PAT numbers relative to the estimates provided in this article, any formal FY27 guidance, and the dividend recommendation from the board. All three will influence the stock’s near-term trajectory. For real-time analysis and SEBI-registered expert views on Neogen Chemicals, visit 

Neogen Chemicals Q4 Results 2026 Date

Get free investment predictions and live Q4 result alerts on Univest.

Neogen Chemicals has scheduled its Q4 FY26 results for May 2026 (Expected). The board of directors will convene to approve the audited consolidated financial statements for the quarter and full year ended March 31, 2026, and to consider a final dividend recommendation. The trading window for designated employees is closed until 48 hours after the results announcement, as per SEBI regulations.

For context on the broader Q4 FY26 results season across the IT and other high-visibility sectors, refer to the earnings calendar below.

Why This Quarter Matters

Q4 FY26 is the final quarter of the financial year — it determines full-year FY26 performance, establishes FY27 estimate baselines, and triggers final dividend announcements. For Neogen Chemicals specifically, Q4 FY26 matters because the stock has delivered a -30% return over the past year, making the quarter’s growth trajectory and management guidance crucial for sentiment recovery.

Institutional investors typically rebalance portfolios at the end of March, and Q4 results provide the data clarity needed to assess whether to increase or reduce positions ahead of the new financial year. Analyst price targets — ranging from Rs 1,420 to Rs 1,450 — will be updated post-results based on the actual Q4 FY26 performance and FY27 guidance.

Neogen Chemicals Q4 FY26 Earnings Estimates

Access premium SEBI-registered research on Univest.

Analysts from brokerages including MOFSL, YES Securities, JM Financial, and ICICI Direct have published Q4 FY26 preview estimates for Neogen Chemicals. Consensus revenue estimate stands at Rs 180–200 Cr, compared to Rs 162 Cr in Q3 FY26. PAT is estimated at Rs 18–24 Cr, with margin projections of EBITDA 18–21%. These estimates are based on publicly available information and may differ from actual results.

Beyond the headline numbers, investors should watch management commentary on two additional points: the FY27 revenue and margin guidance, and the dividend declaration. The FY27 outlook will carry more weight for the stock’s re-rating than the Q4 numbers themselves in the current market environment.

Screen Neogen Chemicals fundamentals, historical financials, and peer comparisons on the Univest Screener.

5 Key Factors That Will Drive Neogen Chemicals Q4 FY26 Performance

Lithium Battery Electrolyte Chemicals

Neogen Chemicals is among the few Indian companies producing electrolyte chemicals for lithium-ion batteries. As India scales up EV manufacturing, domestic demand for these chemicals is accelerating. Q4 FY26 marks the beginning of meaningful revenue contribution from this segment.

Bromination Chemistry Leadership

Neogen is a leading player in bromination chemistry, supplying high-value agrochemicals, pharmaceutical intermediates, and specialty applications. Strong pricing and stable demand in this core segment underpin Q4 revenue estimates.

Pharma Intermediate Export Growth

Global pharma companies continue to diversify API and intermediate sourcing away from China. Neogen’s fluorination and bromination expertise makes it a preferred supplier for regulated market customers.

Capacity Expansion Completion

Neogen’s Dahej facility expansion — which adds significant new chemistry capacity — is coming online in FY26. Q4 will see the first meaningful revenue contribution from the new capacity, adding growth optionality beyond existing products.

R&D Pipeline Commercialisation

Neogen invests approximately 3–4% of revenues in R&D, with a pipeline of novel specialty chemical molecules in development. Any new product commercialisation in Q4 would provide incremental high-margin revenues.

5 Risks to Watch in Neogen Chemicals Q4 FY26

EV Ramp Timeline Uncertainty

The lithium battery chemical segment’s revenue contribution depends on the pace of EV manufacturing scale-up in India. Any delay in EV adoption — due to infrastructure gaps or policy changes — would push revenue ramp further out.

Raw Material Availability

Bromine and fluorine raw materials have supply constraints. Any disruption in key raw material availability could affect production volumes and hence Q4 revenue.

Customer Qualification Cycles

High-value specialty chemical customers require lengthy qualification processes before placing commercial orders. Delays in qualification at new pharma or battery customers could postpone revenue recognition.

Pricing Pressure in Commodity Segments

Some of Neogen’s output competes with lower-cost Chinese manufacturers in less differentiated segments. Pricing pressure in these areas can cap margin upside.

Environmental and Safety Compliance

Specialty chemical manufacturing involving halogens carries environmental and safety compliance requirements. Any incident or regulatory notice could disrupt operations and affect Q4 delivery.

Neogen Chemicals Share Price and Analyst Ratings

Neogen Chemicals is trading at Rs 1,100 as of early April 2026, against a 52-week high of Rs 1,750 and 52-week low of Rs 950. The 1-year return of -30% reflects the broader sector headwinds and company-specific factors discussed in this article. Market capitalisation stands at Rs 2,500 Cr. The -30% return has compressed valuations, creating a potential entry point for investors who believe the FY27 recovery story is intact.

Download the Univest iOS App or Univest Android App to track Neogen Chemicals’s live price, receive SEBI-backed research alerts, and access pre- and post-results analysis from registered analysts.

Conclusion

Neogen Chemicals is at an inflection point driven by lithium battery chemicals and expanding export revenue. Q4 FY26 revenue of Rs 180–200 Cr and PAT of Rs 18–24 Cr represent solid growth, and the Dahej capacity ramp adds medium-term upside. Buy consensus with targets up to Rs 1,450 reflects strong confidence in the specialty chemicals growth story.

This article is for informational and educational purposes only. Investors are advised to consult a SEBI-registered financial advisor before making investment decisions. Historical performance and analyst estimates are not guarantees of future results.

For more Q4 FY26 results previews across sectors, visit Univest Blogs.

Frequently Asked Questions

What is the Neogen Chemicals Q4 results 2026 date?

The Neogen Chemicals Q4 FY26 results date is May 2026 (Expected). The board of directors will meet to approve audited financial statements for the quarter ended March 31, 2026, and consider a final dividend recommendation.

What is the Neogen Chemicals Q4 FY26 PAT estimate?

Analysts estimate Neogen Chemicals Q4 FY26 PAT at Rs 18–24 Cr, based on revenue of Rs 180–200 Cr and margin of EBITDA 18–21%. Actual results may differ from consensus estimates.

What is Neogen Chemicals’s share price ahead of Q4 results?

Neogen Chemicals is trading at Rs 1,100 as of early April 2026. The 52-week high is Rs 1,750 and the low is Rs 950. The 1-year return is -30% and market cap is Rs 2,500 Cr.

Will Neogen Chemicals declare a dividend in Q4 2026?

Neogen Chemicals is expected to consider Rs 3–5 per share as a final dividend at the Q4 FY26 board meeting. The actual dividend will be declared by the board and is subject to the company’s profitability and capital allocation policy.

Which analysts have a Buy rating on Neogen Chemicals?

MOFSL (Target: Rs 1,450), YES Securities (Target: Rs 1,400), JM Financial (Target: Rs 1,380), ICICI Direct (Target: Rs 1,420) have a positive rating on Neogen Chemicals heading into Q4 FY26 results.

What were Neogen Chemicals Q3 FY26 results?

Neogen Chemicals reported revenue of Rs 162 Cr and PAT of Rs 15 Cr in Q3 FY26 (October–December 2025), with margin at EBITDA 17.2%. These form the sequential base against which Q4 FY26 results will be measured.

When do Infosys and TCS announce Q4 results 2026?

TCS announced Q4 FY26 results on April 9, 2026. Read the full TCS Q4 Results 2026 preview. Infosys announced Q4 FY26 results on April 23, 2026. Read the full Infosys Q4 Results 2026 preview.

Is Neogen Chemicals a good investment ahead of Q4 results?

This depends on your risk appetite, investment horizon, and portfolio context. Neogen Chemicals has compelling factors including lithium battery electrolyte chemicals and bromination chemistry leadership, but also faces risks including ev ramp timeline uncertainty. Consult a SEBI-registered financial advisor before making investment decisions. Use the  to assess fundamentals independently.

Disclaimer: Investment in the share market is subject to risk. This article is for informational and educational purposes only and does not constitute investment advice. All financial data and analyst estimates are sourced from publicly available information including NSE/BSE filings and company investor relations pages. Verify all numbers before investing. Consult a SEBI-registered advisor before making investment decisions.

Recent Article

Motisons Jewellers Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Motilal Oswal Financial Services Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Moschip Technologies Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Morepen Laboratories Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Morarjee Textiles Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook